SCHEMBL16357685

SCHEMBL16357685

c1ccc(-c2cc(-n3c4ccccc4c4cc5c(ccn5-c5ccccc5)cc43)cc(-c3ccccc3)n2)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 4/20 0.41
▸ L3MBTL1 Q9Y468 3/20 0.41
▸ ATM Q13315 1/20 0.41
▸ PLA2G4A P47712 1/20 0.34
▸ TERT O14746 1/20 0.33
▸ ACHE P22303 1/20 0.33
▸ BIRC5 O15392 1/20 0.33
▸ KDM4C Q9H3R0 1/20 0.32
▸ PARP1 P09874 1/20 0.32
▸ DHODH Q02127 1/20 0.32
▸ HDAC3 O15379 1/20 0.32
▸ HDAC4 P56524 1/20 0.32
▸ HDAC1 Q13547 1/20 0.32
▸ HDAC7 Q8WUI4 1/20 0.32
▸ HDAC2 Q92769 1/20 0.32
▸ HDAC10 Q969S8 1/20 0.32
▸ HDAC11 Q96DB2 1/20 0.32
▸ HDAC8 Q9BY41 1/20 0.32
▸ HDAC6 Q9UBN7 1/20 0.32
▸ HDAC9 Q9UKV0 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15801463 0.95 KDM4E (0.40) KDM4EL3MBTL1ATMPLA2G4ATERT
SCHEMBL15802315 0.95 KDM4E (0.40) KDM4EL3MBTL1ATMPLA2G4ATERT
SCHEMBL20426297 0.95 L3MBTL1 (0.45) KDM4EL3MBTL1ATMPLA2G4ATERT
SCHEMBL15632025 0.93 KDM4E (0.38) KDM4EL3MBTL1ATMPLA2G4ATERT
SCHEMBL16357502 0.90 L3MBTL1 (0.45) KDM4EL3MBTL1ATMPLA2G4ATERT
SCHEMBL15857342 0.89 L3MBTL1 (0.42) KDM4EL3MBTL1ATMPLA2G4ATERT
SCHEMBL16357395 0.89 L3MBTL1 (0.37) KDM4EL3MBTL1ATMPLA2G4ATERT
SCHEMBL15857148 0.89 L3MBTL1 (0.39) KDM4EL3MBTL1ATMPLA2G4AKMT2A
SCHEMBL15632034 0.88 KDM4E (0.38) KDM4EL3MBTL1ATMPLA2G4ATERT
SCHEMBL16357681 0.88 KDM4E (0.41) KDM4EL3MBTL1ATMBIRC5KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10038146-B2 Organic light-emitting compound and organic electroluminescent device using same DOOSAN CORPORATION (KR) 2018-07-31 — — US disclosed
US-10038146-B2 Organic light-emitting compound and organic electroluminescent device using same DOOSAN CORPORATION (KR) 2018-07-31 — — US disclosed
US-20140374724-A1 ORGANIC LIGHT-EMITTING COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE USING SAME DOOSAN CORPORATION (KR) 2014-12-25 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10038146-B2 Organic light-emitting compound and organic electroluminescent device using same IDO1, IDO2, KYNU KDM4E 1494/4885L3MBTL1 464/4885ATM 4017/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback